Last update 27 Mar 2026

Anhui Provincial Cancer Hospital

Hospital|Anhui Sheng, China

Overview

Tags

Neoplasms
Skin and Musculoskeletal Diseases
Urogenital Diseases
Natural Killer Cell Therapies
Antibody drug conjugate (ADC)

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms2
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Natural Killer Cell Therapies1
Antibody drug conjugate (ADC)1
Top 5 TargetCount
DDR1 x Top I1

Related

2
Drugs associated with Anhui Provincial Cancer Hospital
METR-NK Cells(Anhui Provincial Cancer Hospital)
Target-
Mechanism-
Active Org.
Anhui Provincial Cancer Hospital
Originator Org.
Anhui Provincial Cancer Hospital
Active Indication
Ovarian Epithelial Carcinoma
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
DDR1-DX8951
Target
DDR1 x Top I
Mechanism
DDR1 antagonists [+1]
Active Org.
University of Science & Technology of ChinaUniversity of Science & Technology of China [+1]
Originator Org.
Anhui Provincial Cancer Hospital [+1]
Active Indication
Triple Negative Breast Cancer
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
117
Clinical Trials associated with Anhui Provincial Cancer Hospital
ChiCTR2600118288
/ RecruitingEarly Phase 1IIT
A single-arm phase II clinical study of chemotherapy combined with immunotherapy followed by radiotherapy for residual lesions in oligometastatic esophageal squamous cell carcinoma
NCT07450560
/ Active, not recruitingNot ApplicableIIT
Full-Digital PET Enables Real-time Monitoring of Proton Range
ChiCTR2600118542
/ Not yet recruitingEarly Phase 1IIT
A single-arm, single-center, exploratory study of cetuximab beta combined with definitive chemoradiotherapy for elderly patients with locally advanced unresectable esophageal squamous cell carcinoma
100 Clinical Results associated with Anhui Provincial Cancer Hospital
Login to view more data
0 Patents (Medical) associated with Anhui Provincial Cancer Hospital
Login to view more data
100 Deals associated with Anhui Provincial Cancer Hospital
Login to view more data
100 Translational Medicine associated with Anhui Provincial Cancer Hospital
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 11 Apr 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Phase 2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
METR-NK Cells(Anhui Provincial Cancer Hospital)
Ovarian Epithelial Carcinoma
More
Phase 1/2
DDR1-DX8951
 ( DDR1 x Top I )		Triple Negative Breast Cancer
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free